Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
TRUP
|
Andrew D. Wolff
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 262 Added 25.74% |
-
|
Feb 28
2022 |
NGVT
|
Mary Dean Hall
EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,990 Added 12.06% |
-
|
Feb 28
2022 |
NGVT
|
Steven Paul Hulme
SVP and Pres, APT |
BUY
Grant, award, or other acquisition
|
Direct | 599 Added 50.0% |
-
|
Feb 28
2022 |
PCRX
|
Gary W Pace
Director |
SELL
Open market or private sale
|
Direct | 28,641 Reduced 18.11% |
$1,914,078
$66.83 p/Share
|
Feb 28
2022 |
PCRX
|
Gary W Pace
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 28,641 Added 15.33% |
$315,624
$11.02 p/Share
|
Feb 28
2022 |
AIN
|
Robert Alan Hansen
Senior Vice President & CTO |
SELL
Discretionary transaction
|
Indirect | 2,450 Reduced 100.0% |
$215,086
$87.79 p/Share
|
Feb 28
2022 |
SUM
|
Howard L Lance
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,374 Added 34.33% |
-
|
Feb 28
2022 |
SUM
|
John Raymond Murphy
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,374 Added 24.87% |
-
|
Feb 28
2022 |
SUM
|
Joseph S Cantie
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,374 Added 12.48% |
-
|
Feb 28
2022 |
SUM
|
Steven H Wunning
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,374 Added 12.49% |
-
|
Feb 28
2022 |
SUM
|
Susan A Ellerbusch
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 4,374 Added 15.98% |
-
|
Feb 28
2022 |
SUM
|
Anne P Noonan
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,885 Reduced 4.98% |
$152,510
$31.22 p/Share
|
Feb 28
2022 |
SUM
|
Anne P Noonan
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 16,946 Added 14.73% |
-
|
Feb 28
2022 |
SUM
|
Brian James Harris
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 58,920 Added 21.83% |
-
|
Feb 28
2022 |
SUM
|
Brian James Harris
EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 22,051 Added 12.67% |
-
|
Feb 28
2022 |
SUM
|
Brian James Harris
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 27,122 Reduced 12.86% |
$846,749
$31.22 p/Share
|
Feb 28
2022 |
SUM
|
Karli S. Anderson
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,452 Reduced 12.64% |
$45,331
$31.22 p/Share
|
Feb 28
2022 |
SUM
|
Karli S. Anderson
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,570 Added 28.46% |
-
|
Feb 28
2022 |
SUM
|
Christopher Burke Gaskill
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,427 Reduced 9.18% |
$75,771
$31.22 p/Share
|
Feb 28
2022 |
SUM
|
Christopher Burke Gaskill
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,990 Added 23.21% |
-
|
Feb 28
2022 |
FHB
|
Robert S Harrison
CHAIRMAN, PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 27,523 Reduced 9.13% |
$800,094
$29.07 p/Share
|
Feb 28
2022 |
PRFT
|
Gary Wimberly
Director |
BUY
Grant, award, or other acquisition
|
Direct | 392 Added 3.25% |
$39,945
$101.9 p/Share
|
Feb 28
2022 |
PRFT
|
Gary Wimberly
Director |
BUY
Open market or private purchase
|
Direct | 399 Added 3.42% |
$39,900
$100.0 p/Share
|
Feb 28
2022 |
ABCL
|
Veronique Lecault
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 230,789 Added 12.82% |
$1,998,633
$8.66 p/Share
|
Feb 28
2022 |
MLI
|
Jeffrey Andrew Martin
EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,416 Reduced 1.32% |
$137,301
$56.83 p/Share
|
Feb 28
2022 |
MLI
|
Steffen Sigloch
Chief Manufacturing Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,597 Reduced 2.07% |
$204,418
$56.83 p/Share
|
Feb 28
2022 |
MLI
|
Christopher John Miritello
EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 258 Reduced 0.77% |
$14,662
$56.83 p/Share
|
Feb 28
2022 |
SBRA
|
Richard K Matros
Chair, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct | 8,142 Added 2.14% |
-
|
Feb 28
2022 |
SBRA
|
Michael Lourenco Costa
Executive VP, CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 916 Added 0.72% |
-
|
Feb 28
2022 |
SBRA
|
Craig A. Barbarosh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 776 Added 1.59% |
-
|
Feb 28
2022 |
SBRA
|
Catherine Cusack
Director |
BUY
Grant, award, or other acquisition
|
Direct | 219 Added 1.66% |
-
|
Feb 28
2022 |
SBRA
|
Michael J Foster
Director |
BUY
Grant, award, or other acquisition
|
Direct | 776 Added 1.57% |
-
|
Feb 28
2022 |
SBRA
|
Lynne S Katzmann
Director |
BUY
Grant, award, or other acquisition
|
Direct | 545 Added 2.14% |
-
|
Feb 28
2022 |
SBRA
|
Ann Kono
Director |
BUY
Grant, award, or other acquisition
|
Direct | 228 Added 2.13% |
-
|
Feb 28
2022 |
SBRA
|
Jeffrey A. Malehorn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 780 Added 1.4% |
-
|
Feb 28
2022 |
SBRA
|
Clifton J Porter Ii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 241 Added 2.05% |
-
|
Feb 28
2022 |
CYTK
|
Robert I Blum
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,329 Reduced 3.02% |
$400,140
$35.32 p/Share
|
Feb 28
2022 |
CYTK
|
David Cragg
Chief HR & Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,071 Reduced 1.44% |
$73,148
$35.32 p/Share
|
Feb 28
2022 |
CYTK
|
Ching Jaw
SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,074 Reduced 3.57% |
$73,254
$35.32 p/Share
|
Feb 28
2022 |
CYTK
|
Fady Ibraham Malik
EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct | 3,458 Reduced 2.21% |
$122,137
$35.32 p/Share
|
Feb 28
2022 |
MPLN
|
Mark Tabak
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 15,166 Reduced 0.27% |
$57,024
$3.76 p/Share
|
Feb 28
2022 |
CWK
|
Neil O Johnston |
SELL
Payment of exercise price or tax liability
|
Direct | 8,667 Reduced 30.49% |
$189,981
$21.92 p/Share
|
Feb 28
2022 |
CWK
|
Neil O Johnston |
BUY
Exercise of conversion of derivative security
|
Direct | 28,424 Added 50.0% |
-
|
Feb 28
2022 |
SEAS
|
Christopher Dold
Chief Zoological Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 723 Reduced 1.16% |
$50,169
$69.39 p/Share
|
Feb 28
2022 |
SEAS
|
Christopher Dold
Chief Zoological Officer |
SELL
Open market or private sale
|
Direct | 47,717 Reduced 43.33% |
$3,372,638
$70.68 p/Share
|
Feb 28
2022 |
UAA
|
Aditya Maheshwari
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,899 Reduced 4.72% |
$45,340
$15.64 p/Share
|
Feb 28
2022 |
WBS
|
Daniel Bley
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 13.29% |
$240,720
$60.18 p/Share
|
Feb 28
2022 |
VNT
|
Paul V. Shimp
VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,665 Added 25.92% |
-
|
Feb 28
2022 |
WTS
|
Monica Barry
Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 355 Reduced 12.48% |
$51,102
$143.95 p/Share
|
Feb 28
2022 |
UNVR
|
Stephen D Newlin
Director |
SELL
Open market or private sale
|
Direct | 15,034 Reduced 7.16% |
$466,054
$31.0 p/Share
|
Feb 28
2022 |